BlackRock’s Kronos Bio KRON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-667,399
| Closed | -$551K | – | 5535 |
|
|
2025
Q1 | $551K | Sell |
667,399
-106,877
| -14% | -$103K | ﹤0.01% | 4372 |
|
|
2024
Q4 | $736K | Sell |
774,276
-28,032
| -3% | -$26.4K | ﹤0.01% | 4309 |
|
|
2024
Q3 | $802K | Sell |
802,308
-71,794
| -8% | -$79.5K | ﹤0.01% | 4225 |
|
|
2024
Q2 | $1.08M | Sell |
874,102
-35,348
| -4% | -$36K | ﹤0.01% | 4157 |
|
|
2024
Q1 | $1.18M | Sell |
909,450
-159,054
| -15% | -$181K | ﹤0.01% | 4156 |
|
|
2023
Q4 | $1.34M | Sell |
1,068,504
-312,848
| -23% | -$346K | ﹤0.01% | 4170 |
|
|
2023
Q3 | $1.8M | Sell |
1,381,352
-15,993
| -1% | -$25.8K | ﹤0.01% | 4035 |
|
|
2023
Q2 | $2.4M | Sell |
1,397,345
-1,746,768
| -56% | -$2.77M | ﹤0.01% | 3977 |
|
|
2023
Q1 | $4.59M | Sell |
3,144,113
-62,772
| -2% | -$120K | ﹤0.01% | 3668 |
|
|
2022
Q4 | $5.2M | Sell |
3,206,885
-259,535
| -7% | -$597K | ﹤0.01% | 3703 |
|
|
2022
Q3 | $11.6M | Sell |
3,466,420
-40,185
| -1% | -$181K | ﹤0.01% | 3350 |
|
|
2022
Q2 | $12.8M | Buy |
3,506,605
+104,875
| +3% | +$475K | ﹤0.01% | 3376 |
|
|
2022
Q1 | $24.6M | Buy |
3,401,730
+32,054
| +1% | +$273K | ﹤0.01% | 3039 |
|
|
2021
Q4 | $45.8M | Buy |
3,369,676
+437,155
| +15% | +$6.84M | ﹤0.01% | 2712 |
|
|
2021
Q3 | $61.5M | Buy |
2,932,521
+110,276
| +4% | +$2.37M | ﹤0.01% | 2524 |
|
|
2021
Q2 | $67.6M | Buy |
2,822,245
+1,186,681
| +73% | +$30M | ﹤0.01% | 2496 |
|
|
2021
Q1 | $47.9M | Buy |
1,635,564
+108,876
| +7% | +$3.19M | ﹤0.01% | 2643 |
|
|
2020
Q4 | $45.6M | Buy |
+1,526,688
| New | +$47.9M | ﹤0.01% | 2530 |
|
BlackRock's KRON Position: Q2 2025 in Review
BlackRock sold out of Kronos Bio (KRON) in Q2 2025, closing a stake of 667,399 shares — an estimated $551K sold.
BlackRock first reported a position in KRON in Q4 2020 and held it in 18 quarters. The position peaked at $67.6M in Q2 2021. 0 funds tracked by Wall St. Rank hold KRON as of Q2 2025.
- BlackRock reported no remaining Kronos Bio position as of Q2 2025 after selling out during the quarter.
- BlackRock sold 667,399 Kronos Bio shares in Q2 2025, an estimated $551K.
- BlackRock first reported a position in Kronos Bio in Q4 2020 and held it in 18 quarters.
- BlackRock's Kronos Bio position peaked at $67.6M in Q2 2021.
- 0 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2025.
Based on BlackRock's 13F filing for Q2 2025, filed 12 Aug 2025.